Taking a fresh look at the UK mid-cap TMT sector, Berenberg has upgraded Computacenter and 4imprint to 'buy' from 'hold' and reversed that order as it downgraded Softcat.
Provident Financial and Royal Mail look likely to be knocked out of the FTSE 100 index in the next quarterly reshuffle, with Babcock International potentially joining them.
Whitbread: Barclays upgrades to Equal Weight with target price of 4150p.
Promotional direct marketer 4imprint Group announced its half year results for the six months to 2 July on Tuesday, with revenue improving 17% to $270.22m, from $231.03m.
Finsbury Food shares should be sold, according to Danny Fortson in the Sunday Times' Inside the City column. Although the baker's share have rebounded from 2008's depths of 11p tenfold to more than 110p recently, the bonus payments made to chief executive John Duffy and finance director Stephen Boyd were questioned. Duffy and Boy, who were appointed in 2009 and 2010 respectively, were each awarded £240,000 cash bonuses related to two key deals they tied up, plus their salaries were effectively doubled through bonuses to reward hitting targets for earnings before interest, tax, depreciation and amortisation.
Worldpay: Jefferies reiterates buy with a target price of 340p and Goldman Sachs keeps at buy with a target price of 400p.
Genel Energy: JP Morgan Cazenove reiterates to overweight. Target price: 610.00p. UBS downgrades to neutral, reduces target price to 400.00p.
4imprint Group said it has continued to experience strong organic growth in the period since the announcement of its half year results on 29 July, with the balance between new and existing customer orders consistent with previous periods.
4imprint Group revealed on Thursday it expects its 2014 full year results to be slightly above market expectations, after posting solid growth in the fourth quarter.
Aquarius Platinum: Deutsche Bank shifts target price from 28p to 30p and maintains a buy recommendation.
Aureus Mining: FinnCap lowers target price from 66p to 62p maintaining a buy recommendation.
AstraZeneca: Citi raises target price from 3500p to 4900p and upgrades to buy.
Advanced Medical Solutions: Investec ups target price from 97p to 121p and keeps a buy recommendation.
Printing and marketing group 4imprint grew profits strongly last year and has now sold off its non-core promotional arm to concentrate on its flourishing direct marketing business.
Abcam: Investec reduces target price from 552p to 480p and reiterates its buy recommendation. Numis upgrades from hold to buy with a target price 510p.
Direct marketing and printing group 4Imprint has sold its SPS promotional product wholesaler to a private equity-backed management team for 7.25m pounds.
Buy shares of Crest Nicholson, the Sunday Times's Danny Fortson said. The housebuilder will announce a small annual dividend with its results on January 28th - the first payout since its restructuring and return to the stock market. Boss Stephen Stone is also likely to say Crest has hit its target of 2,500 homes a year early, Fortson wrote in his Inside the City column. The shares have risen 35p to 355p since they floated last year, closing some of the valuation gap with rivals such as Bovis Homes, but house broker Barclays has set a target price of 422p.
Admiral Group: Canaccord Genuity raises target price from 1160p to 1400p and upgrades to hold.
Afren: FinnCap ups target price from 130p to 140p keeping a hold recommendation.